Call Us + 33 1 84 88 31 00

Article R5141-123-18 of the French Public Health Code

The holder of a parallel import authorisation for a proprietary veterinary medicinal product shall immediately inform the marketing authorisation holder in the country of origin of any serious adverse reaction, within the meaning of Article R. 5141-92, concerning the imported proprietary medicinal product, as soon as he is aware of it.

Original in French 🇫🇷
Article R5141-123-18

Dès qu’il en a connaissance, le titulaire d’une autorisation d’importation parallèle d’une spécialité pharmaceutique vétérinaire informe immédiatement le titulaire de l’autorisation de mise sur le marché dans l’Etat de provenance de tout effet indésirable grave, au sens de l’article R. 5141-92, concernant la spécialité importée.

Need help with this article? Get help from a French lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.